What are the ethics of baby gene-editing?

December 1, 2018 by Paul Ricard
Chinese scientist He Jiankui announced this week he had successfully gene-edited babies to prevent them contracting HIV

A Chinese scientist's stunning claim he has pioneered the world's first genetically modified baby has suddenly made the eternal debate over ethics and emerging scientific capabilities pressing and real.

Should everything that becomes technically possible be carried out? For most ethicists the answer is no—but the tricky part is whether it can be prevented.

"It's obvious that everything that is technically feasible is not ethically desirable," said Cynthia Fleury, a member of the French Ethics Committee.

"But to resist that, in a context of deregulated scientific competition, is structurally destined for failure."

It's a question as old as science: Are ethics condemned to constantly nip at the heels of advances that burst forth and take a head start?

Certainly the case in China has brought the debate to the fore.

That country's National Health Commission has ordered a probe into the baby gene-editing announced by scientist He Jiankui, in which he claimed to have tinkered with the DNA of twin girls born a few weeks ago to prevent them contracting HIV. China's government said it was opposed to the experiment, while the scientific world erupted in uproar.

The alleged breakthrough has not been verified. And, after a backlash, He said his trial has been suspended and he has disappeared from public view.

"Good science is not just about generating knowledge in a vacuum. Context and consequences are vitally important, and the consequences of this irresponsible action may be dire indeed," said Dr Sarah Chan, of the University of Edinburgh.

The consequences of the CRISPR gene-editing technology are not fully known, with fears that reckless application might create "monsters"

For all the condemnation, however, it is important to note that many objections were not over the principle of human genetic modification as such, but rather over the way the experiment was carried out.

For instance: it was conducted outside of typical institutional structures, by a lone scientist acting in a way seen by many as premature given the technology used.

He said he employed CRISPR, a technique which allows scientists to remove and replace a strand with pinpoint precision.

But the consequences of the technique are not yet fully known—particularly whether genetic slicing and splicing like that carried over from one generation to the next, with unpredictable effects. The fear is that reckless application of CRISPR might create "monsters".

Another ethical violation raised is that the aim of He's experiment was to protect the babies against AIDS and not to try to cure them of a life-threatening disease.

"Trying to rush the technology"

The concern of the scientific community is that by stepping across established ethical red lines, ensuing public suspicion could crush a field of very promising research.

While CRISPR might spark unease of a future for humanity straight out of an Aldous Huxley novel, it also bears enormous hopes of being able to treat genetic infirmities.

"Trying to rush the technology forwards, skipping vital scientific and ethical steps, could end up setting us all back," warned Dr Kathy Niakan, a biologist at the Francis Crick Institute in London.

Ethics have shifted with some technologies as acceptance has grown—with organ transplants for instance—though human cloning is still seen as unacceptable

Yet that view in itself shows just how far ethics have evolved to the pace of scientific change.

For many decades, the idea of modifying human genomes was simply unthinkable. Now, several international scientific organisations conceive of it being possible, within a rigorous framework.

"You can't just say that something is taboo and that's that, you can't ever think about it again," Anne Cambon-Thomsen, a specialist in immunogenetics and health ethics, and emeritus head of research at France's CNRS national scientific research centre, told AFP.

"An essential point of our humanity is to be able to react by thinking about what is made possible by our technical abilities," said Cambon-Thomsen, who is part of a European Group on Ethics in Science and New Technologies that advises the EU.

Such a shift in acceptance has already been seen, for example, in the field of organ transplants.

Yet human cloning, at present, still remains an intolerable premise. According to Cambon-Thomsen, that's because "we have difficulty in showing some sort of (medical) advantage in cloning".

Following the storm sparked by He Jiankui's announcement, scientists are calling for an international treaty on gene-editing.

But agreeing global regulation "isn't easy because cultures are different—we don't think of human beings in the same way in China as in the West," observed Thierry Magnin, rector at the Catholic University of Lyon.

Magnin, a theologist and physicist, said: "Ethics must be integrated right from the start when technologies are developed, and not come in the end."

Explore further: Gene-edited baby trial 'paused': China scientist

Related Stories

Gene-edited baby trial 'paused': China scientist

November 28, 2018
The Chinese scientist who claims to have created the world's first genetically-edited babies said Wednesday the trial had been paused, following an international outcry over the highly controversial procedure.

Why we are not ready for genetically designed babies

November 28, 2018
The media is buzzing with the surprise news that a Chinese researcher, Jainkui He, has created the world's first genome-edited twins. He did this, ostensibly, to provide resistance to HIV, the virus that causes AIDS.

Recommended for you

Scientists identify method to study resilience to pain

December 14, 2018
Scientists at the Yale School of Medicine and Veterans Affairs Connecticut Healthcare System have successfully demonstrated that it is possible to pinpoint genes that contribute to inter-individual differences in pain.

Researchers uncover molecular mechanisms linked to autism and schizophrenia

December 13, 2018
Since the completion of the groundbreaking Human Genome Project in 2003, researchers have discovered changes to hundreds of places in the DNA, called genetic variants, associated with psychiatric diseases such as autism spectrum ...

CRISPR joins battle of the bulge, fights obesity without edits to genome

December 13, 2018
A weighty new study shows that CRISPR therapies can cut fat without cutting DNA. In a paper published Dec. 13, 2018, in the journal Science, UC San Francisco researchers describe how a modified version of CRISPR was used ...

Noncoding mutations contribute to autism risk

December 13, 2018
A whole-genome sequencing study of nearly 2,000 families has implicated mutations in 'promoter regions' of the genome—regions that precede the start of a gene—in autism. The study, which appears in the December 14 issue ...

New method for studying ALS more effectively

December 13, 2018
The neurodegenerative disease ALS causes motor neuron death and paralysis. However, long before the cells die, they lose contact with muscles as their axons atrophy. Researchers at Karolinska Institutet in Sweden have now ...

Paternal grandfather's high access to food may indicate higher mortality risk in grandsons

December 12, 2018
A paternal grandfather's access to food during his childhood is associated with mortality risk, especially cancer mortality, in his grandson, shows a large three-generational study from Stockholm University. The reason might ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.